Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing quetiapine fumarate (SEROQUEL) to placebo in children and adolescents with Bipolar I disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED